A middle-aged male with a diagnosis of compressive myelopathy, with compression at the thoracic level, ten days post-surgical excision with biopsy suggestive of small round cell tumor (lymphoma, sarcoma) on monitoring for TLS was reviewed by the palliatrist and prescribed the following – radiotherapy, dexamethasone and bisphosphonates?

However this advice was found not to be useful in this scenario for the following discernible reasons –

Radiotherapy was not indicated at the time, due primarily to the close proximity to surgical procedure and presence of an open surgical wound.

Dexamethasone was being given as part of the prephase, and was not expected to be tapered off, instead it was to be stopped abruptly (as per protocol). And its utility as an anti-edema measure, was to be considered questionable in this case as the power at the outset was 0/5 (in all muscle groups of both lower limbs), had refused to improve, and poor neurological outcome was to be expected.
Was the subjective improvement that the patient reported expected to be useful?

An increased risk of TLS with both dexamethasone and radiotherapy was duly noted.

As far as bisphosphonates were concerned the evidence surrounding their use in lymphoma even with a skeletal related event does not have sound pathophysiological basis. Bone disease as a result of direct lymphomatous involvement rather than osteoclast activation is treated with systemic lymphoma directed treatment. That there might be an indication for these bone modifying agents if the round cell tumor was discovered from the pending IHC to be a sarcoma with bone metastases was present but not certain (providing some much needed fodder for thought and an excuse for adding a reference) (1).

The fact that suggestions that come within the scope of medical management of issues in advanced cancer might be considered boundary crossing by purists is not lost on this self-effacing palliatrist, however these might constitute real issues that warrant discussion and documentation (apart from the usual administrative issues surrounding opioid switching from injection tramadol to oral morphine).

The role of the palliatrist needs to extend beyond only pain management, counselling about goals of care and continuity of care, the importance of which need not be forgotten.

Encountering a case of metastatic extradural cord compression where emergent measures were not found to be useful proved to be a lesson in discernment, a chance to re-review existing evidence and engage in effective communication with the treating team.

Are these the complex medical issues that comprise specialist care in the realm of comprehensive management in advanced illness or is there more to follow?

Editor’s take – Recommendations concerning corticosteroids, anticoagulation, radiotherapy, or bone-modifying agents may be viewed by some as extending beyond the traditional remit of palliative medicine. Yet patients with advanced cancer frequently present with complex problems that lie at the interface of symptom control, oncological management, and supportive care. Addressing these issues through evidence appraisal, interdisciplinary communication, and careful clinical reasoning is arguably as much a part of contemporary palliative medicine as opioid prescribing, goals-of-care discussions, or continuity of care.

P.S. One final observation merits mention. A recommendation to consider apixaban ultimately resulted in continuation of therapeutic low-molecular-weight heparin at a higher-than-standard prophylactic dose. Whether this reflected differing interpretations of thromboembolic risk, institutional practice, or evolving clinical judgment illustrates another recurring challenge in multidisciplinary decision making: recommendations are only one part of decision-making, and their implementation is shaped by the treating team’s broader assessment of the patient.

References

Vincenzi, B., Frezza, A. M., Schiavon, G., Santini, D., Dileo, P., Silletta, M., Delisi, D., Bertoldo, F., Badalamenti, G., Baldi, G. G., Zovato, S., Berardi, R., Tucci, M., Silvestris, F., Dei Tos, A. P., Tirabosco, R., Whelan, J. S., & Tonini, G. (2013). Bone metastases in soft tissue sarcoma: A survey of natural history, prognostic value and treatment options. Clinical Sarcoma Research, 3(1), 6. https://doi.org/10.1186/2045-3329-3-6

Cite as – Arora, R. D. (2026). Contemporary Palliatrist Review (CPR1) – Clinical decision making in advanced illness – when the obvious ceases to stand up to closer scrutiny. Zenodo. https://doi.org/10.5281/zenodo.21508376

Disclaimer

Every attempt has been made to safeguard the identity of patients referred to in the vignettes and any circumstances arising out of this academic treatise are completely unintended on the part of the author. The author does not intend to cause any harm to another individual’s or organization’s reputation and has tried his level best to ensure that identities are fiercely protected.

Artificial intelligence tools, primarily Claude (Anthropic), have been employed for evidence synthesis and language refinement. They do not replace critical scholarship, clinical experience, or editorial judgment. Final responsibility for all interpretations, factual accuracy, originality of synthesis, and the quality of the published material rests entirely with the Founder and Editor.